Analysis of Off-Target Effects in CRISPR-Edited Cells
Use next-generation sequencing (NGS) to detect and quantify on-target and off-target editing events in CRISPR-edited cells at predicted or experimentally nominated genomic loci. Prepare targeted NGS libraries using using Beckman Coulter Life Sciences extraction reagents, IDT rhAmpSeq CRISPR Analysis System, and a Beckman Coulter Life Sciences Biomek i-Series Automated Workstation. With the Genedata Biopharma platform, automate sequencing data analysis with workflows designed to characterize potential off-target sites and other genome editing outcomes.
Off-Target Analysis Products
Biomek i5 Automated Workstation Liquid Handler
<p>Optimize dependability and walk-away time. The Biomek i5 is a recent addition to our liquid handling portfolio, representing the best of what has made Biomek an industry-leading brand - combined with enhancements suggested by customers around the globe.</p> <ul> <li>Ideal for medium- to high-throughput workflows</li> <li>25 deck positions</li> <li>0.5 µL-1,000 µL (Multichannel) or 0.5 µL-5,000 µL (Span-8) pipetting volume ranges</li> <li>Single Multichannel head (96/384) or Span-8 pipetting with gripper</li> </ul>
View ProductsBiomek i7 Automated Workstation
The most powerful and comprehensive Biomek available. High-throughput 45 deck positions 0.5 - 5,000 µL pipetting volume range Single or dual heads
View ProductsGenedata Biopharma Platform: Biopharma Automation & AI
Genedata transforms biopharma R&D through automation, advanced analytics, and AI. As the first biologics-native technology company, we lead digitalization and enable data-driven decision-making for biopharma organizations worldwide. The Genedata Biopharma Platform combines a unified data model with workflow automation and embedded AI to accelerate and optimize end-to-end discovery and development of biologics and other modalities.
View Products
